Colorcon launches on-dose authentication technology platform

23 Dec 2019

Next-generation pharmaceutical supply-chain security for tracking product from plant to patient.

Colorcon has announced the development and availability of On-Dose Authentication capability to provide track and trace functionality for supply chain security.

Colorcon launches on-dose authentication technology platform

The seamless integration of molecular taggants from Applied DNA Sciences (ADNAS) into an Opadry fully formulated film coating system significantly reduces the risks associated with counterfeit and falsified medications entering the supply chain.

This first commercial offering is the culmination of extensive collaboration between Colorcon and ADNAS to help pharmaceutical companies enhance patient safety and reduce risk by using intelligent data and analytics gathered from authentication of the dosage form itself. By better understanding the vulnerabilities of a complex global supply chain, drug manufacturers can make informed decisions regarding distribution networks and deploy preventative measures to address counterfeiting and product diversion issues.

Dr Ali Rajabi-Siahboomi, Vice President/Chief Scientific Officer at Colorcon said: “With new guidelines from regulators and accessible technology, on-dose solutions provide a more robust and reliable means of identifying and deterring counterfeiting, verifying product authenticity, and ensuring product traceability. Through extensive research and development, Colorcon has created a unique coating system to address this global problem.”

Kelly Boyer, General Manager, Film Coatings at Colorcon explained: “On-dose authentication technology represents the next generation in pharmaceutical supply-chain security by providing a powerful tool for tracking product from plant to patient. By seamlessly enabling authentication, these digitized coatings confirm the quality and origin of medicines thereby safeguarding both patients and brands.”

Read More

Related news

FDA success for MedPharm Centre of Excellence

FDA success for MedPharm Centre of Excellence

14 Feb 2020

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

Read more 
Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing

Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing

12 Feb 2020

Partnership will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Read more 
Catalent to manufacture first-in-class mAb targeting solid tumours

Catalent to manufacture first-in-class mAb targeting solid tumours

11 Feb 2020

ZM008 could have potential benefits for the treatment of prostate cancer.

Read more 
BD completes clinical trial for its wearable injector

BD completes clinical trial for its wearable injector

11 Feb 2020

The pre-filled, pre-assembled injector is designed to prioritize safety, convenience and usability while delivering high-value drug treatments in the comfort of an in-home environment.

Read more 
Innovation awarded at Pharmapack

Innovation awarded at Pharmapack

10 Feb 2020

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Read more 
2020 - a year for 'big answers' rather than 'big data'

2020 - a year for 'big answers' rather than 'big data'

7 Feb 2020

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

Read more 
Recipharm acquisition to make it a top 5 global CDMO?

Recipharm acquisition to make it a top 5 global CDMO?

6 Feb 2020

CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.

Read more 
New Velesco Pharma clinical manufacturing facility begins operations

New Velesco Pharma clinical manufacturing facility begins operations

5 Feb 2020

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

Read more 
Colorcon starts No-Tox ink manufacturing at new UK facility

Colorcon starts No-Tox ink manufacturing at new UK facility

4 Feb 2020

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Read more 
Hovione announces key patent grants for its large dose DPI

Hovione announces key patent grants for its large dose DPI

4 Feb 2020

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

Read more